Latest Institutional Placements News

Cyclopharm Limited posted a fifth consecutive record half-year revenue of $17.5 million, propelled by a 74% jump in US Technegas® sales and a doubling of revenue-generating US sites. New US clinical guidelines naming Technegas® as the preferred ventilation imaging agent underpin a robust growth outlook despite a wider net loss.

True North Copper Limited (ASX:TNC) has opened a Share Purchase Plan allowing eligible shareholders to buy up to $30,000 of shares at $0.37 each, a 14% discount to recent trading prices. The SPP complements an institutional placement, targeting a combined raise of $20 million to fund the Mt Oxide Copper Project.

Liberty Metals has kicked off its maiden exploration at the newly acquired Oko North and South projects in Guyana’s prolific Oko gold district, targeting drill-ready anomalies with cutting-edge in-field gold detection technology.

Megaport has posted a 37% jump in FY26 revenue to $312 million, driven by strategic acquisitions and a broadening platform across compute, network, and storage. The company raised over $1 billion to fund AI-focused contracts and infrastructure growth.

Pioneer Credit (ASX:PNC) has delivered a standout FY26 with a 245% surge in net profit after tax to $23.1 million, driven by disciplined debt portfolio investments and refinancing gains. The company sets ambitious targets for FY27-FY29, including a $35 million NPAT goal.

Southern Cross Electrical Engineering’s FY26 underlying profits surged despite a $46.1 million WestConnex arbitration settlement dragging statutory net profit sharply lower. The group declared a record dividend and raised FY27 EBITDA guidance by 30%.

Synertec Corporation Limited (ASX:SOP) reported a 19% revenue increase in FY26 alongside its first net operating cash inflow since FY19. The company raised approximately A$6 million through an institutional placement to support working capital and growth initiatives while reaffirming FY27 revenue guidance.

L1 Group Limited delivered a standout FY26 with statutory profit up 79% and underlying net profit nearly doubling, driven by merger synergies and strong fund performance.

CurveBeam AI has launched a Share Purchase Plan offering eligible shareholders a 10% discount on new shares, aiming to raise up to $2 million alongside a pending $5 million placement.

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Eden Innovations reported strong EdenCrete® trial results in India and North America, strategic hires for EdenShield® in defence markets, and completed a $4.05 million placement, ending the quarter debt-free with $5.2 million cash.

Arafura Rare Earths has taken a decisive step forward on its Nolans Project, announcing a Final Investment Decision and securing over A$700 million in cash and term deposits as it prepares to start construction in September 2026.